Reference Hub: Long term outcome of Progressive Multifocal Leukoencephalopathy after Tysabri exposure

An organized set of primary and secondary sources covering clinical background, drug-safety signals, and patient-safety considerations.

Detailed topic guide

A Closer Look at Long term outcome of Progressive Multifocal Leukoencephalopathy after Tysabri exposure

In-depth context and analysis on this topic for researchers and advocates.

ClinicalTrials.gov

Reference: ClinicalTrials.gov

Authoritative source for clinical, regulatory, and public-health background reading.

Mayo Clinic — Diseases & Conditions

Reference: Mayo Clinic — Diseases & Conditions

Authoritative source for clinical, regulatory, and public-health background reading.

U.S. Food and Drug Administration (FDA)

Reference: U.S. Food and Drug Administration (FDA)

Authoritative source for clinical, regulatory, and public-health background reading.